PODD Stock — Insulet Corp.

Insulet Corp. (PODD)

Updated October 16, 2026.

PODD is a Stock. Total return is 784.1% over the past 19.4 years, 160.3 points ahead of SPY at 623.8%.

Insulet Corporation develops and manufactures insulin delivery systems, principally its Omnipod platform products, which include automated insulin delivery systems integrated with continuous glucose monitors and smartphone-controlled insulin management systems for people with insulin-dependent diabetes. The company sells its products through pharmacy channels and independent distributors in the United States and internationally, and also provides drug delivery pods for Amgen's Neulasta Onpro chemotherapy support system. Insulet does not currently distribute dividends.

PODD performance versus SPY

Price and return data through 2026-10-16.

Total return is 784.1% over the past 19.4 years, 160.3 points ahead of SPY at 623.8%. Over the past year its total return — price change plus distributions reinvested — is -55.4%. Its deepest 1-year drawdown was 62.3%.

PODD key facts

Asset type

Stock

Asset class

Equity

Inception date

05/15/2007

Distribution frequency

None

Last close

$141.10 (as of 2026-10-16)

Market cap

$9,785,877,479

Average volume

1618208.0

Beta

1.101

Payout ratio

0.0%

P/E ratio

26.72

Forward P/E

54.9451

EPS

$5.28

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

PODD risks and drawbacks

The deepest 1-year drawdown on record here is 62.3%.

Who may consider PODD — and who may not

It is a weaker fit for investors who need monthly cash flow (PODD does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on PODD

• All tickers starting with P

Tagged: Healthcare.

Frequently asked questions